Additionally, PDEs have been implicated in obesity and T2D, as evidenced by a PDE4 knockout mouse model with reduced adiposity and the associated inflammation, alongside a separate mouse model treated with a PDE4 inhibitor that improved glucose tolerance and insulin sensitivity [91,92]. Here, PDE4A is linked to obesity disorder.